Logo image of LILAK

LIBERTY LATIN AMERIC-CL C (LILAK) Stock Fundamental Analysis

USA - NASDAQ:LILAK - BMG9001E1286 - Common Stock

7.75 USD
-0.28 (-3.49%)
Last: 10/10/2025, 8:40:56 PM
7.75 USD
0 (0%)
After Hours: 10/10/2025, 8:40:56 PM
Fundamental Rating

3

LILAK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 36 industry peers in the Diversified Telecommunication Services industry. LILAK has a medium profitability rating, but doesn't score so well on its financial health evaluation. LILAK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

LILAK had negative earnings in the past year.
LILAK had a positive operating cash flow in the past year.
LILAK had negative earnings in each of the past 5 years.
LILAK had a positive operating cash flow in each of the past 5 years.
LILAK Yearly Net Income VS EBIT VS OCF VS FCFLILAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

The Return On Assets of LILAK (-9.82%) is worse than 91.67% of its industry peers.
The Return On Equity of LILAK (-192.88%) is worse than 86.11% of its industry peers.
The Return On Invested Capital of LILAK (4.98%) is better than 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LILAK is below the industry average of 6.38%.
The last Return On Invested Capital (4.98%) for LILAK is above the 3 year average (4.30%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -9.82%
ROE -192.88%
ROIC 4.98%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
LILAK Yearly ROA, ROE, ROICLILAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

LILAK's Operating Margin of 14.37% is fine compared to the rest of the industry. LILAK outperforms 63.89% of its industry peers.
LILAK's Operating Margin has declined in the last couple of years.
The Gross Margin of LILAK (78.03%) is better than 94.44% of its industry peers.
In the last couple of years the Gross Margin of LILAK has remained more or less at the same level.
Industry RankSector Rank
OM 14.37%
PM (TTM) N/A
GM 78.03%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
LILAK Yearly Profit, Operating, Gross MarginsLILAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LILAK is destroying value.
Compared to 1 year ago, LILAK has less shares outstanding
LILAK has more shares outstanding than it did 5 years ago.
LILAK has a worse debt/assets ratio than last year.
LILAK Yearly Shares OutstandingLILAK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
LILAK Yearly Total Debt VS Total AssetsLILAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 0.15, we must say that LILAK is in the distress zone and has some risk of bankruptcy.
LILAK's Altman-Z score of 0.15 is on the low side compared to the rest of the industry. LILAK is outperformed by 75.00% of its industry peers.
LILAK has a debt to FCF ratio of 37.83. This is a negative value and a sign of low solvency as LILAK would need 37.83 years to pay back of all of its debts.
LILAK has a Debt to FCF ratio of 37.83. This is in the lower half of the industry: LILAK underperforms 61.11% of its industry peers.
A Debt/Equity ratio of 12.50 is on the high side and indicates that LILAK has dependencies on debt financing.
LILAK has a Debt to Equity ratio of 12.50. This is amonst the worse of the industry: LILAK underperforms 86.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 12.5
Debt/FCF 37.83
Altman-Z 0.15
ROIC/WACC0.69
WACC7.19%
LILAK Yearly LT Debt VS Equity VS FCFLILAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.08 indicates that LILAK should not have too much problems paying its short term obligations.
LILAK has a Current ratio (1.08) which is comparable to the rest of the industry.
A Quick Ratio of 1.08 indicates that LILAK should not have too much problems paying its short term obligations.
LILAK has a Quick ratio of 1.08. This is comparable to the rest of the industry: LILAK outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 1.08
LILAK Yearly Current Assets VS Current LiabilitesLILAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

3

3. Growth

3.1 Past

The earnings per share for LILAK have decreased strongly by -1346.34% in the last year.
LILAK shows a decrease in Revenue. In the last year, the revenue decreased by -2.15%.
LILAK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.88% yearly.
EPS 1Y (TTM)-1346.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-863.64%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-2.8%

3.2 Future

Based on estimates for the next years, LILAK will show a very strong growth in Earnings Per Share. The EPS will grow by 26.25% on average per year.
LILAK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.89% yearly.
EPS Next Y12.25%
EPS Next 2Y41.13%
EPS Next 3Y28.75%
EPS Next 5Y26.25%
Revenue Next Year-1.01%
Revenue Next 2Y-1.76%
Revenue Next 3Y0.12%
Revenue Next 5Y1.89%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LILAK Yearly Revenue VS EstimatesLILAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
LILAK Yearly EPS VS EstimatesLILAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2 -3

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LILAK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LILAK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LILAK Price Earnings VS Forward Price EarningsLILAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 -200 400

4.2 Price Multiples

80.56% of the companies in the same industry are more expensive than LILAK, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, LILAK is valued a bit cheaper than the industry average as 77.78% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.19
EV/EBITDA 5.88
LILAK Per share dataLILAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

A more expensive valuation may be justified as LILAK's earnings are expected to grow with 28.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.13%
EPS Next 3Y28.75%

0

5. Dividend

5.1 Amount

No dividends for LILAK!.
Industry RankSector Rank
Dividend Yield N/A

LIBERTY LATIN AMERIC-CL C

NASDAQ:LILAK (10/10/2025, 8:40:56 PM)

After market: 7.75 0 (0%)

7.75

-0.28 (-3.49%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners64.79%
Inst Owner Change0%
Ins Owners11.61%
Ins Owner ChangeN/A
Market Cap1.55B
Analysts76
Price Target8.92 (15.1%)
Short Float %18.32%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2677.51%
Min EPS beat(2)-4518.74%
Max EPS beat(2)-836.29%
EPS beat(4)0
Avg EPS beat(4)-4375.62%
Min EPS beat(4)-10589%
Max EPS beat(4)-836.29%
EPS beat(8)2
Avg EPS beat(8)-5900.02%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.76%
Min Revenue beat(2)-4.03%
Max Revenue beat(2)-3.49%
Revenue beat(4)0
Avg Revenue beat(4)-3.47%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.18%
Revenue beat(12)0
Avg Revenue beat(12)-3.31%
Revenue beat(16)1
Avg Revenue beat(16)-2.55%
PT rev (1m)13.31%
PT rev (3m)13.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-399.71%
EPS NY rev (3m)-429.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF 7.19
P/OCF 2.09
P/B 2.55
P/tB N/A
EV/EBITDA 5.88
EPS(TTM)-5.93
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)1.08
FCFY13.91%
OCF(TTM)3.71
OCFY47.84%
SpS22.04
BVpS3.04
TBVpS-20.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.82%
ROE -192.88%
ROCE 6.3%
ROIC 4.98%
ROICexc 5.25%
ROICexgc 10.26%
OM 14.37%
PM (TTM) N/A
GM 78.03%
FCFM 4.89%
ROA(3y)-2.32%
ROA(5y)-2.88%
ROE(3y)-23.98%
ROE(5y)-23.6%
ROIC(3y)4.3%
ROIC(5y)3.96%
ROICexc(3y)4.63%
ROICexc(5y)4.26%
ROICexgc(3y)9.72%
ROICexgc(5y)8.98%
ROCE(3y)5.45%
ROCE(5y)5.02%
ROICexcg growth 3Y-0.27%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-1.91%
ROICexc growth 5Y1.9%
OM growth 3Y-7.22%
OM growth 5Y-4.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y0.13%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 12.5
Debt/FCF 37.83
Debt/EBITDA 4.86
Cap/Depr 56.57%
Cap/Sales 11.93%
Interest Coverage 1.06
Cash Conversion 47.45%
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 1.08
Altman-Z 0.15
F-Score4
WACC7.19%
ROIC/WACC0.69
Cap/Depr(3y)62.1%
Cap/Depr(5y)64.9%
Cap/Sales(3y)12.93%
Cap/Sales(5y)13.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1346.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-863.64%
EPS Next Y12.25%
EPS Next 2Y41.13%
EPS Next 3Y28.75%
EPS Next 5Y26.25%
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y-2.54%
Revenue growth 5Y2.88%
Sales Q2Q%-2.8%
Revenue Next Year-1.01%
Revenue Next 2Y-1.76%
Revenue Next 3Y0.12%
Revenue Next 5Y1.89%
EBIT growth 1Y20.02%
EBIT growth 3Y-9.58%
EBIT growth 5Y-1.84%
EBIT Next Year892.93%
EBIT Next 3Y117.29%
EBIT Next 5Y83.24%
FCF growth 1Y9.83%
FCF growth 3Y-8.29%
FCF growth 5Y-8.09%
OCF growth 1Y-8.37%
OCF growth 3Y-9.38%
OCF growth 5Y-3.81%